Article

New Global Cooperation Landscape

Published on 03.05

A Powerful Alliance! Shinying Med and Epower Consulting Join Forces to Help Chinese Medical Enterprises Set Sail for Southeast Asian and Middle Eastern Markets

Shinying (Shanghai) Medical Technology Co., Ltd. ("Shinying Med"), an excellent partner in the field of healthcare compliance, and Epower Consulting, a top consulting firm deeply rooted in the Southeast Asian and Middle Eastern markets, have officially signed an exclusive strategic cooperation agreement for medical products in Southeast Asia and the Middle East in Shanghai. The two parties announced the establishment of a deep strategic partnership, integrating their respective advantageous resources to create a one-stop medical product export service platform oriented towards sales landing. This will assist Chinese healthcare enterprises in efficiently expanding into the Southeast Asian and Middle Eastern markets and achieving new breakthroughs in overseas sales.

A Powerful Combination of Emerging Compliance Forces and Local Channel Resources

Shinying Med was founded in 2023, with its founding team having nearly twenty years of experience in the pharmaceutical and medical device fields. Ms. Chen Yao, the founder, holds an MBA in the Greater Health Industry from East China University of Science and Technology. She leads the team in focusing on global registration, compliance services, and overseas channel development for pharmaceuticals, medical devices, food, and cosmetics, dedicated to clearing the "last mile" for Chinese enterprises going global.

Yiwei Consulting is a global market strategy partner focusing on the medical, healthcare, and artificial intelligence fields. Since 2007, founder Mr. Li Yaoguang has been promoting scientific traditional Chinese medicine and integrated diagnostic systems of traditional Chinese and Western medicine in Singapore. In recent years, the business footprint has successfully expanded to Southeast Asia (Malaysia, Singapore, Indonesia, Thailand) and the Middle East (Saudi Arabia, UAE, Dubai) markets. With rich experience in helping enterprises overcome channel challenges, formulate sales strategies, and achieve localized operations, it is a key force in promoting sales implementation in the region.

Focusing on sales orientation, precisely developing strategic markets

This cooperation will first take Malaysia, the largest medical device market in ASEAN, as the core pivot to help Chinese enterprises quickly enter the regional market. Malaysia, with its positioning as an "advanced manufacturing and R&D alternative center," has seen rapid growth in its medical market driven by both policy and capital. In addition, as the global authority in the halal industry, the country's halal certification system provides an important channel for Chinese enterprises to enter the markets of 57 member states of the Organization of Islamic Cooperation, with huge sales potential.

The two parties will focus on the actual sales needs of target markets, providing a full-process service from product access, channel docking, market promotion to localized implementation, precisely solving the core pain points faced by Chinese enterprises in overseas sales.

Mr. Jamaludin, Senior Consultant of Eway Consulting and former Malaysian [Title/Role - context needed for precise translation]

Yiwei Consulting Senior Consultant and former Pharmaniaga Malaysia Commercial Director Mr. Jamaludin introduced

One-stop sales empowerment, promoting "Made in China" to the world

The core of this cooperation lies in integrating XiYing Medical's professional capabilities in global registration and compliance with Yiwei Consulting's channel network and local insights in Southeast Asia and the Middle East markets. The two parties will jointly build a sales-oriented one-stop overseas service system to help Chinese pharmaceutical and medical device manufacturers quickly complete product certification, channel establishment, and sales implementation, effectively enhancing the penetration and market share of "Made in China" in target markets.

This collaboration not only embodies the high degree of synergy between the two parties in their business operations but also serves as a positive response to the demand for Chinese healthcare companies to expand their sales overseas. The partnership will propel medical export services into a new phase of "sales-driven, full-process empowerment," providing sustained momentum for the internationalization of China's healthcare industry.

The signing ceremony was held in a warm atmosphere, with distinguished guests in attendance. Mr. Wang Leijian, Head of the Business Service Center of Fengchuanggu Science and Technology Base Incubation Enterprises; Mr. Li Honglin from Fangteng Pharmaceutical; Ms. Lu Jie from Jiading Advanced Technology Transformation and Incubation Center; Mr. Yu Zhiyong, Founder & CEO of E-Future; Mr. Zhang Jieying, Business Head of Applus RTD; Mr. Xu Xiaoyan, General Manager of Shanghai Zhonggao Information; Dr. Qi Lifeng, Chairman of Shanghai Nao Bio; Ethan Jin from Glowmeda Medical Technology; Mr. Liu Zhijun, Deputy General Manager of Jiaxing E-Lab Pharmaceutical; Ms. Chen Zhu, Quality Manager; and Mr. Chen Hao, Manager of the Jiaxing Branch of Shanghai Pudong Software Park Huizhi Technology, along with many other industry guests, jointly witnessed this significant moment.

Group photo of guests

(This article is for policy interpretation and knowledge sharing in the medical industry only. The content is for reference only. Please cite the original source if you wish to reprint.)